nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—TBXAS1—prostate cancer	0.349	0.775	CbGaD
Sulfasalazine—CYP3A5—prostate cancer	0.0713	0.158	CbGaD
Sulfasalazine—SLCO1B1—Cabazitaxel—prostate cancer	0.0311	0.0855	CbGbCtD
Sulfasalazine—SLCO1B1—Estrone—prostate cancer	0.0304	0.0836	CbGbCtD
Sulfasalazine—PTGS2—prostate cancer	0.0302	0.0671	CbGaD
Sulfasalazine—ABCG2—Cabazitaxel—prostate cancer	0.0247	0.0679	CbGbCtD
Sulfasalazine—ABCG2—Estrone—prostate cancer	0.0241	0.0664	CbGbCtD
Sulfasalazine—ABCC2—Ethinyl Estradiol—prostate cancer	0.0238	0.0655	CbGbCtD
Sulfasalazine—SLCO1B1—Conjugated Estrogens—prostate cancer	0.0199	0.0547	CbGbCtD
Sulfasalazine—CYP3A5—Flutamide—prostate cancer	0.0185	0.0509	CbGbCtD
Sulfasalazine—ABCC2—Conjugated Estrogens—prostate cancer	0.0174	0.048	CbGbCtD
Sulfasalazine—SLCO1B1—Estradiol—prostate cancer	0.0174	0.048	CbGbCtD
Sulfasalazine—ABCG2—Conjugated Estrogens—prostate cancer	0.0158	0.0434	CbGbCtD
Sulfasalazine—ABCG2—Mitoxantrone—prostate cancer	0.0143	0.0395	CbGbCtD
Sulfasalazine—ABCG2—Estradiol—prostate cancer	0.0138	0.0381	CbGbCtD
Sulfasalazine—CYP3A5—Cabazitaxel—prostate cancer	0.0137	0.0376	CbGbCtD
Sulfasalazine—CYP3A5—Estrone—prostate cancer	0.0134	0.0368	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—prostate cancer	0.01	0.0275	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—prostate cancer	0.00988	0.0272	CbGbCtD
Sulfasalazine—ABCC2—Docetaxel—prostate cancer	0.00915	0.0252	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—prostate cancer	0.00904	0.0249	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—prostate cancer	0.00835	0.023	CbGbCtD
Sulfasalazine—ABCG2—Docetaxel—prostate cancer	0.00827	0.0228	CbGbCtD
Sulfasalazine—CYP3A5—Estradiol—prostate cancer	0.00767	0.0211	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—prostate cancer	0.00682	0.0188	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—prostate cancer	0.00617	0.017	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—prostate cancer	0.00501	0.0138	CbGbCtD
Sulfasalazine—CYP3A5—Docetaxel—prostate cancer	0.00458	0.0126	CbGbCtD
Sulfasalazine—ACAT1—prostate gland—prostate cancer	0.00266	0.0542	CbGeAlD
Sulfasalazine—TBXAS1—prostate gland—prostate cancer	0.00222	0.0453	CbGeAlD
Sulfasalazine—CHUK—prostate gland—prostate cancer	0.00198	0.0404	CbGeAlD
Sulfasalazine—SLC46A1—prostate gland—prostate cancer	0.00198	0.0404	CbGeAlD
Sulfasalazine—ACAT1—renal system—prostate cancer	0.00181	0.0369	CbGeAlD
Sulfasalazine—SLC46A1—seminal vesicle—prostate cancer	0.00167	0.0342	CbGeAlD
Sulfasalazine—CHUK—epithelium—prostate cancer	0.00145	0.0297	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—prostate cancer	0.00137	0.0279	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—prostate cancer	0.00137	0.0279	CbGeAlD
Sulfasalazine—CHUK—renal system—prostate cancer	0.00135	0.0275	CbGeAlD
Sulfasalazine—IKBKB—prostate gland—prostate cancer	0.00135	0.0275	CbGeAlD
Sulfasalazine—PLA2G1B—renal system—prostate cancer	0.00127	0.0259	CbGeAlD
Sulfasalazine—ACAT1—testis—prostate cancer	0.00117	0.0239	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—prostate cancer	0.00114	0.0234	CbGeAlD
Sulfasalazine—ALOX5—prostate gland—prostate cancer	0.00111	0.0228	CbGeAlD
Sulfasalazine—SLC7A11—renal system—prostate cancer	0.00111	0.0227	CbGeAlD
Sulfasalazine—TBXAS1—testis—prostate cancer	0.000978	0.02	CbGeAlD
Sulfasalazine—IKBKB—urethra—prostate cancer	0.000901	0.0184	CbGeAlD
Sulfasalazine—SLC46A1—testis—prostate cancer	0.000872	0.0178	CbGeAlD
Sulfasalazine—CHUK—testis—prostate cancer	0.000872	0.0178	CbGeAlD
Sulfasalazine—ACAT1—lymph node—prostate cancer	0.000848	0.0173	CbGeAlD
Sulfasalazine—PPARG—prostate gland—prostate cancer	0.000837	0.0171	CbGeAlD
Sulfasalazine—PLA2G1B—testis—prostate cancer	0.00082	0.0167	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—prostate cancer	0.000812	0.612	CbGdCrCtD
Sulfasalazine—ALOX5—urethra—prostate cancer	0.000746	0.0152	CbGeAlD
Sulfasalazine—ABCC2—prostate gland—prostate cancer	0.000736	0.015	CbGeAlD
Sulfasalazine—SLC7A11—testis—prostate cancer	0.000718	0.0147	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—prostate cancer	0.000709	0.0145	CbGeAlD
Sulfasalazine—SLCO1B1—renal system—prostate cancer	0.000661	0.0135	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—prostate cancer	0.000632	0.0129	CbGeAlD
Sulfasalazine—CHUK—lymph node—prostate cancer	0.000632	0.0129	CbGeAlD
Sulfasalazine—PPARG—epithelium—prostate cancer	0.000615	0.0126	CbGeAlD
Sulfasalazine—IKBKB—testis—prostate cancer	0.000593	0.0121	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—prostate cancer	0.000575	0.0117	CbGeAlD
Sulfasalazine—PPARG—renal system—prostate cancer	0.000571	0.0116	CbGeAlD
Sulfasalazine—PPARG—urethra—prostate cancer	0.00056	0.0114	CbGeAlD
Sulfasalazine—ABCG2—prostate gland—prostate cancer	0.000537	0.0109	CbGeAlD
Sulfasalazine—ABCC2—renal system—prostate cancer	0.000501	0.0102	CbGeAlD
Sulfasalazine—CYP3A5—prostate gland—prostate cancer	0.000498	0.0102	CbGeAlD
Sulfasalazine—ALOX5—testis—prostate cancer	0.000491	0.01	CbGeAlD
Sulfasalazine—ABCG2—seminal vesicle—prostate cancer	0.000454	0.00926	CbGeAlD
Sulfasalazine—PTGS1—prostate gland—prostate cancer	0.000447	0.00913	CbGeAlD
Sulfasalazine—PPARG—bone marrow—prostate cancer	0.000431	0.0088	CbGeAlD
Sulfasalazine—IKBKB—lymph node—prostate cancer	0.00043	0.00877	CbGeAlD
Sulfasalazine—PTGS2—prostate gland—prostate cancer	0.000428	0.00873	CbGeAlD
Sulfasalazine—PTGS1—seminal vesicle—prostate cancer	0.000378	0.00772	CbGeAlD
Sulfasalazine—PPARG—testis—prostate cancer	0.000369	0.00753	CbGeAlD
Sulfasalazine—PTGS2—seminal vesicle—prostate cancer	0.000362	0.00738	CbGeAlD
Sulfasalazine—ABCG2—urethra—prostate cancer	0.000359	0.00733	CbGeAlD
Sulfasalazine—ALOX5—lymph node—prostate cancer	0.000356	0.00727	CbGeAlD
Sulfasalazine—CYP3A5—renal system—prostate cancer	0.000339	0.00693	CbGeAlD
Sulfasalazine—PTGS1—epithelium—prostate cancer	0.000329	0.00671	CbGeAlD
Sulfasalazine—ABCC2—testis—prostate cancer	0.000324	0.00661	CbGeAlD
Sulfasalazine—PTGS2—epithelium—prostate cancer	0.000314	0.00641	CbGeAlD
Sulfasalazine—PTGS1—renal system—prostate cancer	0.000305	0.00622	CbGeAlD
Sulfasalazine—PTGS2—renal system—prostate cancer	0.000292	0.00595	CbGeAlD
Sulfasalazine—Sulfaphenazole—CYP2A6—prostate cancer	0.00029	0.194	CrCbGaD
Sulfasalazine—PTGS2—urethra—prostate cancer	0.000286	0.00584	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—prostate cancer	0.000276	0.00564	CbGeAlD
Sulfasalazine—PPARG—lymph node—prostate cancer	0.000267	0.00545	CbGeAlD
Sulfasalazine—Vismodegib—CYP2C19—prostate cancer	0.000264	0.176	CrCbGaD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—prostate cancer	0.000258	0.194	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—prostate cancer	0.000258	0.194	CbGdCrCtD
Sulfasalazine—ABCG2—testis—prostate cancer	0.000236	0.00482	CbGeAlD
Sulfasalazine—ABCC2—lymph node—prostate cancer	0.000235	0.00479	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP2E1—prostate cancer	0.000225	0.151	CrCbGaD
Sulfasalazine—PTGS2—bone marrow—prostate cancer	0.00022	0.0045	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—prostate cancer	0.00022	0.147	CrCbGaD
Sulfasalazine—PTGS1—testis—prostate cancer	0.000197	0.00402	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—prostate cancer	0.000187	0.125	CrCbGaD
Sulfasalazine—ABCG2—lymph node—prostate cancer	0.000171	0.0035	CbGeAlD
Sulfasalazine—Vismodegib—CYP3A4—prostate cancer	0.000168	0.112	CrCbGaD
Sulfasalazine—PTGS1—lymph node—prostate cancer	0.000143	0.00292	CbGeAlD
Sulfasalazine—Sulfadiazine—CYP3A4—prostate cancer	0.000142	0.0948	CrCbGaD
Sulfasalazine—PTGS2—lymph node—prostate cancer	0.000137	0.00279	CbGeAlD
Sulfasalazine—PTGS2—Metabolism—GSTP1—prostate cancer	1.56e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BAD—prostate cancer	1.55e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIF1A—prostate cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1B—prostate cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1A—prostate cancer	1.55e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—prostate cancer	1.54e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ITPR1—prostate cancer	1.54e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAV1—prostate cancer	1.54e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—RXRA—prostate cancer	1.53e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—prostate cancer	1.53e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1B—prostate cancer	1.52e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—prostate cancer	1.52e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—LEP—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CG—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APC—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CG—prostate cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—prostate cancer	1.5e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CAV1—prostate cancer	1.5e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGF—prostate cancer	1.49e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IRS1—prostate cancer	1.49e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—prostate cancer	1.49e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KDR—prostate cancer	1.48e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—COMT—prostate cancer	1.48e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAV1—prostate cancer	1.47e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—prostate cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CB—prostate cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—prostate cancer	1.47e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—prostate cancer	1.46e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CTNNB1—prostate cancer	1.46e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—prostate cancer	1.46e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TYMS—prostate cancer	1.45e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—prostate cancer	1.45e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—prostate cancer	1.45e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ITPR1—prostate cancer	1.44e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GSK3B—prostate cancer	1.44e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ESR1—prostate cancer	1.44e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—prostate cancer	1.44e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTNNB1—prostate cancer	1.43e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—prostate cancer	1.43e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—INS—prostate cancer	1.43e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—prostate cancer	1.43e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—INS—prostate cancer	1.43e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—prostate cancer	1.42e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—LPL—prostate cancer	1.41e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BAD—prostate cancer	1.41e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.41e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CREBBP—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CAV1—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREBBP—prostate cancer	1.4e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—prostate cancer	1.38e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—prostate cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—prostate cancer	1.38e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APC—prostate cancer	1.37e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CG—prostate cancer	1.37e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TYMS—prostate cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP1A1—prostate cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—prostate cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—prostate cancer	1.36e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ERCC2—prostate cancer	1.35e-06	1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IRS1—prostate cancer	1.35e-06	1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGF—prostate cancer	1.35e-06	1e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—prostate cancer	1.35e-06	1e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CG—prostate cancer	1.34e-06	9.98e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—prostate cancer	1.33e-06	9.91e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAP2K1—prostate cancer	1.33e-06	9.9e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—prostate cancer	1.33e-06	9.87e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CD—prostate cancer	1.33e-06	9.86e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—LPL—prostate cancer	1.32e-06	9.84e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—INS—prostate cancer	1.32e-06	9.84e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CD—prostate cancer	1.32e-06	9.83e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—prostate cancer	1.32e-06	9.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BAD—prostate cancer	1.31e-06	9.77e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GSK3B—prostate cancer	1.31e-06	9.73e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—prostate cancer	1.31e-06	9.73e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—prostate cancer	1.3e-06	9.63e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CREBBP—prostate cancer	1.3e-06	9.63e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—INS—prostate cancer	1.29e-06	9.6e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP1A1—prostate cancer	1.28e-06	9.5e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APC—prostate cancer	1.27e-06	9.46e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—prostate cancer	1.27e-06	9.46e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—INS—prostate cancer	1.27e-06	9.45e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—prostate cancer	1.27e-06	9.44e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—prostate cancer	1.27e-06	9.43e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ERCC2—prostate cancer	1.27e-06	9.43e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF2—prostate cancer	1.27e-06	9.42e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREBBP—prostate cancer	1.27e-06	9.4e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGF—prostate cancer	1.26e-06	9.35e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IRS1—prostate cancer	1.26e-06	9.35e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—prostate cancer	1.25e-06	9.31e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—prostate cancer	1.25e-06	9.31e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—prostate cancer	1.25e-06	9.29e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—prostate cancer	1.25e-06	9.29e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—prostate cancer	1.25e-06	9.29e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CREBBP—prostate cancer	1.25e-06	9.26e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARA—prostate cancer	1.25e-06	9.25e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CD—prostate cancer	1.23e-06	9.13e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—GSK3B—prostate cancer	1.22e-06	9.08e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JAK2—prostate cancer	1.21e-06	9.03e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—prostate cancer	1.21e-06	9e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAP2K1—prostate cancer	1.21e-06	8.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—INS—prostate cancer	1.21e-06	8.96e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CD—prostate cancer	1.2e-06	8.92e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—prostate cancer	1.19e-06	8.86e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—prostate cancer	1.19e-06	8.82e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—prostate cancer	1.19e-06	8.81e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—prostate cancer	1.18e-06	8.8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—prostate cancer	1.18e-06	8.79e-06	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—prostate cancer	1.18e-06	8.78e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CD—prostate cancer	1.18e-06	8.78e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREBBP—prostate cancer	1.18e-06	8.77e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—prostate cancer	1.18e-06	8.77e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAV1—prostate cancer	1.17e-06	8.7e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARA—prostate cancer	1.17e-06	8.69e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB2—prostate cancer	1.17e-06	8.69e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—prostate cancer	1.16e-06	8.63e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CB—prostate cancer	1.16e-06	8.6e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—prostate cancer	1.16e-06	8.6e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CB—prostate cancer	1.15e-06	8.57e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF2—prostate cancer	1.15e-06	8.54e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—prostate cancer	1.15e-06	8.52e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—prostate cancer	1.14e-06	8.44e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—prostate cancer	1.13e-06	8.42e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAP2K1—prostate cancer	1.13e-06	8.37e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CD—prostate cancer	1.12e-06	8.32e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.12e-06	8.31e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—prostate cancer	1.12e-06	8.29e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—prostate cancer	1.11e-06	8.24e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—prostate cancer	1.11e-06	8.23e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JAK2—prostate cancer	1.1e-06	8.18e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAV1—prostate cancer	1.1e-06	8.17e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—prostate cancer	1.09e-06	8.12e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—prostate cancer	1.09e-06	8.08e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1B—prostate cancer	1.08e-06	8.04e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—prostate cancer	1.08e-06	7.99e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—prostate cancer	1.07e-06	7.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF2—prostate cancer	1.07e-06	7.96e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CB—prostate cancer	1.07e-06	7.96e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CG—prostate cancer	1.07e-06	7.92e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—prostate cancer	1.06e-06	7.89e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—prostate cancer	1.06e-06	7.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB2—prostate cancer	1.06e-06	7.88e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—prostate cancer	1.06e-06	7.87e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—prostate cancer	1.06e-06	7.85e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CB—prostate cancer	1.05e-06	7.77e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—prostate cancer	1.03e-06	7.67e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CB—prostate cancer	1.03e-06	7.65e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JAK2—prostate cancer	1.03e-06	7.63e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CTNNB1—prostate cancer	1.02e-06	7.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—prostate cancer	1.02e-06	7.58e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—INS—prostate cancer	1.01e-06	7.5e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—prostate cancer	1.01e-06	7.47e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—prostate cancer	1e-06	7.46e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—prostate cancer	1e-06	7.45e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—prostate cancer	1e-06	7.45e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CG—prostate cancer	1e-06	7.44e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—prostate cancer	1e-06	7.43e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—prostate cancer	9.99e-07	7.42e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—prostate cancer	9.97e-07	7.41e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CREBBP—prostate cancer	9.89e-07	7.35e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB2—prostate cancer	9.89e-07	7.35e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—prostate cancer	9.86e-07	7.33e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1B—prostate cancer	9.82e-07	7.29e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CB—prostate cancer	9.76e-07	7.25e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—prostate cancer	9.63e-07	7.16e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—prostate cancer	9.62e-07	7.15e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—prostate cancer	9.61e-07	7.14e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—prostate cancer	9.54e-07	7.09e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—prostate cancer	9.51e-07	7.06e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—INS—prostate cancer	9.48e-07	7.05e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—prostate cancer	9.41e-07	6.99e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CD—prostate cancer	9.38e-07	6.97e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—prostate cancer	9.36e-07	6.96e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CREBBP—prostate cancer	9.29e-07	6.9e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CTNNB1—prostate cancer	9.27e-07	6.89e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—prostate cancer	9.26e-07	6.88e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—prostate cancer	9.24e-07	6.87e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1B—prostate cancer	9.16e-07	6.8e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—prostate cancer	9.09e-07	6.76e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—prostate cancer	9.06e-07	6.73e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—prostate cancer	9.04e-07	6.72e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—prostate cancer	9e-07	6.69e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—prostate cancer	8.96e-07	6.66e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—prostate cancer	8.91e-07	6.62e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—prostate cancer	8.9e-07	6.61e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—prostate cancer	8.89e-07	6.61e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—prostate cancer	8.89e-07	6.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—prostate cancer	8.85e-07	6.58e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—prostate cancer	8.83e-07	6.56e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CD—prostate cancer	8.81e-07	6.54e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—prostate cancer	8.73e-07	6.49e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CTNNB1—prostate cancer	8.65e-07	6.43e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—prostate cancer	8.62e-07	6.41e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—prostate cancer	8.48e-07	6.3e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—prostate cancer	8.45e-07	6.28e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—prostate cancer	8.43e-07	6.27e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—prostate cancer	8.38e-07	6.23e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—prostate cancer	8.32e-07	6.18e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—prostate cancer	8.28e-07	6.16e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—prostate cancer	8.26e-07	6.14e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—prostate cancer	8.2e-07	6.1e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CB—prostate cancer	8.17e-07	6.07e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—prostate cancer	8.16e-07	6.07e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—prostate cancer	8.1e-07	6.02e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—prostate cancer	8.08e-07	6.01e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—prostate cancer	8.06e-07	5.99e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—prostate cancer	8.04e-07	5.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—prostate cancer	7.82e-07	5.81e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CB—prostate cancer	7.68e-07	5.7e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—prostate cancer	7.65e-07	5.69e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—prostate cancer	7.61e-07	5.65e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—prostate cancer	7.54e-07	5.6e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—prostate cancer	7.51e-07	5.58e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—prostate cancer	7.49e-07	5.57e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—prostate cancer	7.35e-07	5.46e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—prostate cancer	7.32e-07	5.44e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—prostate cancer	7.06e-07	5.25e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—prostate cancer	7.05e-07	5.24e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—prostate cancer	7.03e-07	5.23e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—prostate cancer	7.01e-07	5.21e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—prostate cancer	6.99e-07	5.19e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—prostate cancer	6.94e-07	5.16e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—prostate cancer	6.85e-07	5.09e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—prostate cancer	6.8e-07	5.05e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—prostate cancer	6.73e-07	5e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—prostate cancer	6.63e-07	4.93e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—prostate cancer	6.53e-07	4.85e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—prostate cancer	6.47e-07	4.81e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—prostate cancer	6.38e-07	4.74e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—prostate cancer	6.33e-07	4.7e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—prostate cancer	6.28e-07	4.66e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—prostate cancer	6.23e-07	4.63e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—prostate cancer	6.17e-07	4.58e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—prostate cancer	5.95e-07	4.42e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—prostate cancer	5.76e-07	4.28e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—prostate cancer	5.74e-07	4.27e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—prostate cancer	5.65e-07	4.2e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—prostate cancer	5.34e-07	3.96e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—prostate cancer	5.27e-07	3.91e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—prostate cancer	5.21e-07	3.87e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—prostate cancer	5.13e-07	3.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—prostate cancer	4.98e-07	3.7e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—prostate cancer	4.86e-07	3.61e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—prostate cancer	4.68e-07	3.48e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—prostate cancer	4.07e-07	3.02e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—prostate cancer	3.82e-07	2.84e-06	CbGpPWpGaD
